Clinical data | |
---|---|
Trade names | Dilaterol, Spiropent, Ventipulmin, others[1] |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Oral (tablets, oral solution) |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 89–98% (orally) |
Metabolism | Hepatic (negligible) |
Elimination half-life | 36–48 hours |
Excretion | Feces and urine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.048.499 |
Chemical and physical data | |
Formula | C12H18Cl2N2O |
Molar mass | 277.19 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Clenbuterol is a sympathomimetic amine used by sufferers of breathing disorders as a decongestant and bronchodilator. People with chronic breathing disorders such as asthma use this as a bronchodilator to make breathing easier. It is most commonly available as the hydrochloride salt, clenbuterol hydrochloride.[2]
It was patented in 1967 and came into medical use in 1977.[3]